Bisoprolol + Cilnidipine + Telmisartan Tablet Franchise in Ahmedabad

Cardiac Care Tablet Supplier in Mumbai

Hypertension Medicine Distributor in Delhi

Cardiology Pharma Franchise in Bangalore

Bisoprolol Cilnidipine Tablet Stockist in Hyderabad
Cardiac Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /bisoprolol-fumarate-5mg-cilnidipine-10mg-telmisartan-40mg-tablet

About the Product

Description


Bisopair CT 5 Tablet contains Bisoprolol 5mg + Cilnidipine 10mg + Telmisartan 40mg, a triple-action therapy designed for effective management of hypertension and cardiovascular health. Bisoprolol helps regulate heart rate, Cilnidipine relaxes blood vessels for improved circulation, and Telmisartan blocks angiotensin receptors to maintain optimal blood pressure.

This combination is widely trusted by prescribers for its efficacy and patient tolerance, ensuring steady demand. Patients benefit from improved blood pressure control, cardiac protection, and enhanced treatment adherence, making therapy more effective and convenient.

For franchise partners, Bisopair CT 5 Tablet is a high-demand cardiovascular product with excellent market potential. Its proven triple-action mechanism and prescriber confidence make it a profitable addition to any cardiac portfolio, helping expand business reach and strengthen market presence.

With growing incidence of hypertension and cardiovascular disorders, Bisopair CT 5 Tablet provides sustainable sales opportunities and portfolio growth, making it an ideal choice for partners in the cardiac care segment.


Common side effects may include dizziness, headache, fatigue, swelling of ankles, palpitations, or mild gastrointestinal discomfort. Rarely, patients may experience hypotension, bradycardia, or allergic reactions. Any severe or persistent symptoms should be reported promptly to a healthcare professional.

Bisopair CT 5 Tablet is indicated for the management of essential hypertension in adults, especially in patients who need intensified therapy for optimal blood pressure control. It is also suitable for patients with cardiovascular risk factors such as diabetes, kidney disease, or a history of heart disease.

Bisopair CT 5 Tablet should be taken exactly as prescribed by a physician. Regular monitoring of blood pressure, heart rate, and kidney function is recommended. Patients with severe liver or kidney impairment, heart block, or low blood pressure should use this medication cautiously. Do not discontinue therapy abruptly.

Store Bisopair CT 5 Tablet in a cool, dry place below 25°C, protected from sunlight and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bisoprolol Fumarate 5mg + Cilnidipine 10mg + Telmisartan 40mg Tablet in the PCD pharma franchise market?

This advanced triple-combination has strong demand in the cardiology and chronic hypertension segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular care portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of moderate to severe hypertension, resistant hypertension, and cardiovascular risk control. Bisoprolol reduces heart rate and cardiac workload Cilnidipine relaxes blood vessels and reduces vascular resistance Telmisartan blocks angiotensin receptors and helps control BP long-term Together, they provide triple-action blood pressure control, strengthening a strong chronic cardiovascular portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong cardiology prescriptions, high-value chronic therapy demand, long-term patient usage, hospital and specialist clinic supply, reliable supply chain support, and good margins in cardiovascular medicines.

How can I become a distributor or franchise partner for this tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.